Other FDA Advisories: Recall of u...

Other FDA Advisories:

Recall of urine processing kit. The U meat and Drug Administration (FDA) has issued a Class I recall of the ProbeTec ET Urine Processing Kit, which guards for Chlamydia and gonorrhea. Because the kit may cause false-negative originates the FDA is concerned that an patients might not receive treatment. If left untreated, these infections can worsen or cause further disease transmission and complications in pregnant patients.

Combination therapy may cause hepatitis. Studies have ground that healthy volunteers could contract drug-induced hepatitis with marked transaminase elevations after taking simultaneous regimens of rifampin (Rifadin) and ritonavir (Norvir)-boosted saquinavir (Fortovase). The drug's manufacturer make acceptables that physicians not prescribe rifampin for patients taking ritonavir-boosted saquinavir. The combination regimen is used as an antiretroviral therapy for human immunodeficiency virus infection.

Warning labels ordered for sum of two units eczema medications. The FDA has announced that it will require warning labels for pimecrolimus (Elidel) and tacrolimus (Protopic), topical creams used to manage eczema. latter studies on animals and limited case studies forward humans have found an increased cancer risk associated with the pair medications. Although more studies are needinessed the FDA recommends that physicians prescribe these medications solitary as a second-line, short-term therapy for patients unresponsive to other treatments. The FDA also advises physicians to avoid prescribing them to children younger than brace years and to persons with weakened immune systems

COPYRIGHT 2005 American Academy of Family Physicians

COPYRIGHT 2005 Gale Group